BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7687720)

  • 1. Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imaging.
    Zierhut W; Rudin M; Robertson E; Zerwes HG; Novosel D; Evenou JP; Stirnimann R; Hof RP
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):937-46. PubMed ID: 7687720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of spirapril on left ventricular hypertrophy due to volume overload in rats.
    Umemura K; Zierhut W; Rudin M; Novosel D; Robertson E; Pedersen B; Hof RP
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):375-81. PubMed ID: 1378117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial magnetic resonance imaging based assessment of the early effects of an ACE inhibitor on postinfarction left ventricular remodeling in rats.
    Prunier F; Marescaux L; Franconi F; Thia A; Legras P; Lejeune JJ; Furber A
    Can J Physiol Pharmacol; 2005 Dec; 83(12):1109-15. PubMed ID: 16462910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.
    Al-Shafei AI; Wise RG; Gresham GA; Carpenter TA; Hall LD; Huang CL
    J Physiol; 2002 Jan; 538(Pt 2):555-72. PubMed ID: 11790819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
    Romano M; Cardei S; de Arcangelis E; Monteforte I; Capaldo M; Muto P; Marchegiano R; Kilama MO; Condorelli M
    Am Heart J; 1997 Mar; 133(3):268-72. PubMed ID: 9060793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving beta-blockade after myocardial infarction. CONSENSUS II multiecho study group.
    Bonarjee VV; Carstensen S; Caidahl K; Nilsen DW; Edner M; Lindvall K; Snapinn SM; Berning J
    Am Heart J; 1996 Jul; 132(1 Pt 1):71-7. PubMed ID: 8701878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction.
    Schulman SP; Weiss JL; Becker LC; Guerci AD; Shapiro EP; Chandra NC; Siu C; Flaherty JT; Coombs V; Taube JC
    Am J Cardiol; 1995 Oct; 76(11):764-70. PubMed ID: 7572651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
    Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a new angiotensin-converting enzyme inhibitor (idrapril) in rats with left ventricular dysfunction after myocardial infarction.
    Jeremic G; Masson S; Luvara G; Porzio S; Lagrasta C; Riva E; Olivetti G; Latini R
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):347-54. PubMed ID: 8907795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction.
    Baur LH; Schipperheyn JJ; van der Wall EE; van der Velde EA; Schalij MJ; van Eck-Smit BL; van der Laarse A; Voogd PJ; Sedney MI; Reiber JH; Bruschke AV
    Eur Heart J; 1997 Aug; 18(8):1313-21. PubMed ID: 9458425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
    Patten RD; Aronovitz MJ; Einstein M; Lambert M; Pandian NG; Mendelsohn ME; Konstam MA
    Clin Sci (Lond); 2003 Feb; 104(2):109-18. PubMed ID: 12546633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure. Effects on survival, hemodynamics, and cardiovascular remodeling.
    Mulder P; Devaux B; Richard V; Henry JP; Wimart MC; Thibout E; Macé B; Thuillez C
    Circulation; 1997 Mar; 95(5):1314-9. PubMed ID: 9054865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitor therapy affects left ventricular mass in patients with ejection fraction > 40% after acute myocardial infarction.
    Johnson DB; Foster RE; Barilla F; Blackwell GG; Roney M; Stanley AW; Kirk K; Orr RA; van der Geest RJ; Reiber JH; Dell'Italia LJ
    J Am Coll Cardiol; 1997 Jan; 29(1):49-54. PubMed ID: 8996294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of enalapril initiated early after acute myocardial infarction on heart failure parameters, with reference to clinical class and echocardiographic determinants. CONSENSUS II Multi-Echo Study Group.
    Edner M; Bonarjee VV; Nilsen DW; Berning J; Carstensen S; Caidahl K
    Clin Cardiol; 1996 Jul; 19(7):543-8. PubMed ID: 8818434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.